Evidence map›Paper›PMID 39868025›Full record

ArticleFrontiers in artificial intelligence2024

Artificial intelligence-based framework for early detection of heart disease using enhanced multilayer perceptron.

Monir Abdullah

Abstract read
In one paragraph

Article in Frontiers in artificial intelligence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Machine Learning-Based Ensemble Predictive Model for Cardiovascular Disease Prevention.The International journal of angiology : official publication of the International College of Angiology, Inc · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Monir AbdullahDepartment of Computer Science and Artificial Intelligence, College of Computing and Information Technology, University of Bisha, Bisha, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac disease refers to diseases that affect the heart such as coronary artery diseases, arrhythmia and heart defects and is amongst the most difficult health conditions known to humanity. According to the WHO, heart disease is the foremost cause of mortality worldwide, causing an estimated 17.8 million deaths every year it consumes a significant amount of time as well as effort to figure out what is causing this, especially for medical specialists and doctors. Manual methods for detecting cardiac disease are biased and subject to medical specialist variance. In this aspect, machine learning algorithms have proved to be effective and dependable alternatives for detecting and classifying patients who are affected by heart disease. Precise and prompt detection of human heart disease can assist in avoiding heart failure within the initial stages and enhance patient survival. This study proposed a novel Enhanced Multilayer Perceptron (EMLP) framework complemented by data refinement techniques to enhance predictive accuracy. The classification model asses using the CDC cardiac disease dataset and achieved 92% accuracy by surpassing all the traditional methods. The proposed framework demonstrates significant potential for the early detection and prediction of cardiac-related diseases. Experimental results indicate that the Enhanced Multilayer Perceptron (EMLP) model outperformed the other algorithms in terms of accuracy, precision, F1-score, and recall, underscoring its efficacy in cardiac disease detection.

Indexed as

cardiac diseasecardiovascular diseasesdetectionheart diseasemachine learningmultilayer perceptron

Identifiers

PMID39868025
PMCPMC11760590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.